Overview
Aflofarm Farmacja Polska is a Polish pharmaceutical company that has operated in healthcare for 30 years and has led Poland’s over-the-counter market since 2012, with brands such as Desmoxan, Neosine and Dafurag. Its portfolio includes more than 180 brands, including prescription and OTC medicines, medical devices, cosmetics and dietary supplements; the company employs over 1,500 people and exports products to 31 countries.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-11-01. Active
12 1240 3044 1111 0000 2957 4038
31 1440 1101 0000 0000 1616 7916- 38 1020 3916 0000 0102 0297 3329
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $1.1M$1,084,493 |
Buildings and premises | $21.2M$21,150,763 |
Public aid
17 public aid cases recorded, with a total value of $11,836,574.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 30, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $0$0 | Małopolska Agencja Rozwoju Regionalnego S.A. | |
| Oct 30, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $0$0 | Instytut Nauk Społeczno-Ekonomicznych sp. z o.o. + limited partnership | |
| Jun 30, 2023 | Regional investment aid | $1.4M$1,402,939 | PIERWSZY MAZOWIECKI URZĄD SKARBOWY W WARSZAWIE |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-06-01 | Rozbudowa zaplecza badawczo-rozwojowego w Aflofarm w celu zwiększenia aktywności B+R w obszarze opracowania nowych produktów leczniczych, wyrobów medycznych i kosmetyków | $725.7K$725,719 | Regionalny Program Operacyjny Województwa Łódzkiego na lata 2014-2020 |
Tenders
No recorded participation in tenders.
Public sector contracts
Aflofarm Farmacja Polska is the contractor in one public sector contract, worth PLN 1.59k.
| Public buyer | Value | |
|---|---|---|
| Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych I Administracji w Koszalinie | PLN 1,595 |
Trademarks
Aflofarm Farmacja Polska holds 471 active trademarks registered with the Polish Patent Office. 34 applications are pending. 325 marks have expired or were not registered. The first mark was filed in 1988.
| Mark | Protected until | |
|---|---|---|
| osemivir(word) | Mar 12, 2036 | |
| more(word) | Jan 30, 2036 | |
| ASECURIN(word) | Dec 2, 2035 | |
| aflofarm(word) | Dec 2, 2035 | |
| ALTAMEDIC(word) | Dec 2, 2035 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Waste generation | Active |
Authorized Representatives
Manner of representation
For making declarations of will on behalf of the company with respect to both property and non-property rights and obligations, and for signing on its behalf, two members of the management board or a member of the management board jointly with a commercial proxy are authorized.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Zbigniew Furman (75) | 138,719 | $2,341,960.43 | 33.0013% |
Jacek Furman (51) | 126,097 | $2,128,866.15 | 29.9985% |
Wojciech Maciej Furman (47) | 126,097 | $2,128,866.15 | 29.9985% |
Others | 29,431 | $496,876.69 | 7.0017% |
Andrzej Zbigniew Furman, Jacek Furman and Wojciech Maciej Furman hold a combined 93% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
TREC Nutritionsp. z o.o. | 18,165.86 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakłady Farmaceutyczne PolpharmaS.A. | $1,364,908,839.78 | polpharma.pl | ||
| Adamed PharmaS.A. | $541,927,181.76 | adamed.com.pl | ||
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $160,174,284.28 | anpharm.pl | ||
| Biofarmsp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| Farmak Internationalsp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl |
Change history
| Date | Event | |
|---|---|---|
| 2012-10-25 | Share capital change (13,100,000.00 PLN → 26,271,500.00 PLN) | |
| 2002-01-22 | Share capital change (50,000.00 PLN → 13,100,000.00 PLN) | |
| 2001-09-06 | Name change (Aflo Farmacja Polska → Aflofarm Farmacja Polska) | |
| 2001-05-23 | Entered in the register |
FAQ
Last updated: 2026-07-15